Expression of Wip1 in kidney carcinoma and its correlation with tumor metastasis and clinical significance (Q38980592)

8 September 2017

title

Expression of Wip1 in kidney carcinoma and its correlation with tumor metastasis and clinical significance (English)

1 reference

8 September 2017

1 reference

G G Sun

1

1 reference

8 September 2017

Y D Wang

series ordinal

2

1 reference

8 September 2017

Q Liu

series ordinal

3

1 reference

8 September 2017

W N Hu

series ordinal

4

1 reference

8 September 2017

publication date

28 June 2014

1 reference

Pathology Oncology Research

8 September 2017

published in

1 reference

8 September 2017

volume

21

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

219-224

1 reference

Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

Adult renal cancer in Senegal: Current epidemiological, clinical features, profile's evolution over the two past decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

[How accurate is the correlation between clinical and pathological TNM stages in renal tumours?].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

p53 Regulates LIF expression in human medulloblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

Nuclear factor-kappaB (NF-kappaB) is a novel positive transcriptional regulator of the oncogenic Wip1 phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

Maternal Wnt/β-catenin signaling coactivates transcription through NF-κB binding sites during Xenopus axis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-014-9811-9

PPM1D is a potential target for 17q gain in neuroblastoma

21 January 2018

1 reference

12 December 2020

The importance of prognosis in cancer screening in patients with chronic kidney disease

1 reference

12 December 2020

The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase

1 reference

12 December 2020

[Expression of proto-oncogene Wip1 in breast cancer and its clinical significance]

1 reference

12 December 2020

Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway

1 reference

12 December 2020

10.1007/S12253-014-9811-9

Identifiers

DOI

1 reference

8 September 2017

1 reference